Trial Profile
Two-stage study to evaluate the effects of temozolomide and bevacizumab in two-stage patients with uterine leiomyosarcoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary)
- Indications Leiomyosarcoma
- Focus Therapeutic Use
- 05 Jun 2017 Results (n=19) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 02 Sep 2015 New trial record